NHLBI Innovation and Commercialization Ecosystem: Product Development Support and Program Evaluation

Closed Pre-Solicitation Posted

Not the latest version. See the latest special notice from .

Solicitation number
75N98026R00085
Agency
Responses due
Set-aside
Total Small Business

Opportunity facts

Place of performance
Bethesda, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Heart, Lung, and Blood Institute (NHLBI), Innovation and Commercialization Office, is conducting market research to identify qualified small business sources for innovation and commercialization ecosystem support services, with capability statements due June 18, 2026. This procurement is reserved for total small business under NAICS 541611 (Administrative Management and General Management Consulting Services), with a $24.5 million size standard.

The anticipated requirement spans four primary task areas: data and evaluation strategy (developing evaluation frameworks, data collection methodologies, performance metrics, and analytical systems to assess program effectiveness across SBIR/STTR and other translational programs); partner engagement and innovator resources (maintaining an AI-driven partnering platform with matchmaking algorithms to connect innovators with partners, investors, and capital sources); program coordination and logistics (managing bi-weekly internal meetings, external stakeholder meetings, minimum 25 webinars annually, and responding to inquiries within 1–2 business days); and innovator support and entrepreneurial education (designing and delivering entrepreneurship programs including support for 3–4 Entrepreneurs-in-Residence, one-on-one consultations, pitch coaching, 1–2 formal annual courses with 2 offerings each, 3–4 virtual webinars and 2–4 innovation showcases annually supporting up to 250 attendees, and semi-annual conflict-of-interest management).

The base period runs September 12, 2026 through September 11, 2027, with two optional one-year periods extending through September 11, 2029. Work is performed at the contractor's site with virtual meetings conducted via Microsoft Teams. Capability statements (maximum 10 single-sided pages, 12-point font minimum) must reference Sources Sought Notice No. 75N98026R00085 and be submitted electronically to Jennifer Henselmann (Contracting Officer) and Donna Cornish (Acquisition Specialist) at the NIH Office of Acquisition & Logistics Management, Division B, Bethesda, Maryland.

Notice text

The National Heart, Lung, and Blood Institute (NHLBI), Innovation and Commercialization Office (I&C), is conducting market research to identify qualified small business sources capable of providing innovation and commercialization ecosystem support services. The anticipated requirement includes program evaluation and analytics, partner engagement and commercialization support, operation and enhancement of an AI-enabled partnering platform, program coordination and logistics, entrepreneurial education and mentoring, and support for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) initiatives.

The Government is seeking capability statements from small business concerns capable of performing the activities described in the attached draft Statement of Work. Responses will be used for acquisition planning purposes, including assessing the availability of qualified small business sources and determining an appropriate acquisition strategy.

(See additional details in the attached Sources Sought Notice)

Files

Notice history

Notice Type Posted
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension Latest special notice Special Notice
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity